Somatostatin analogue SMS 201-995 in type I diabetes mellitus: Initial experience after repeated administration

Scandinavian Journal of Gastroenterology

Volumn 21, Issue S119, 1986, Pages 166-169

  Plewe, G ^a,b   Nolken G ^a,b   Krause, U ^a,b   Pozo, E Del ^a,b   Beyer, J ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Sandoz Pharma Ltd   (Switzerland)

Author keywords

Diabetes mellitus; Growth hormone; Proliferative retinopathy; Somatomedin C; Somatostatin

Indexed keywords

DRUG DERIVATIVE; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN; INSULIN; SOMATOSTATIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; PATHOPHYSIOLOGY; CLINICAL ARTICLE; DIABETIC RETINOPATHY; DRUG THERAPY; ENDOCRINE SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; PREVENTION; PRIORITY JOURNAL; RETINOPATHY; THERAPY; VISUAL SYSTEM;

ADULT; BLOOD GLUCOSE; CLINICAL TRIALS; DIABETES MELLITUS, INSULIN-DEPENDENT; DRUG ADMINISTRATION SCHEDULE; FEMALE; GROWTH HORMONE; HUMAN; INSULIN-LIKE GROWTH FACTOR I; MALE; OCTREOTIDE; SOMATOSTATIN;

EID: 0022507073     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365528609087446     Document Type: Article

References (15)